Praxis Precision Medicines, Inc. (PRAX)
252.96
-5.96
(-2.30%)
USD |
NASDAQ |
Oct 23, 16:00
252.90
-0.06
(-0.02%)
After-Hours: 20:00
Praxis Precision Medicines Enterprise Value : 6.304B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.304B |
| October 22, 2026 | 6.471B |
| October 21, 2026 | 6.402B |
| October 20, 2026 | 6.626B |
| October 19, 2026 | 6.506B |
| October 16, 2026 | 5.992B |
| October 15, 2026 | 6.173B |
| October 14, 2026 | 5.915B |
| October 13, 2026 | 6.036B |
| October 12, 2026 | 6.260B |
| October 09, 2026 | 6.497B |
| October 08, 2026 | 6.600B |
| October 07, 2026 | 7.004B |
| October 06, 2026 | 7.063B |
| October 05, 2026 | 7.159B |
| October 02, 2026 | 7.492B |
| October 01, 2026 | 7.252B |
| September 30, 2026 | 7.373B |
| September 29, 2026 | 7.087B |
| September 28, 2026 | 7.217B |
| September 25, 2026 | 7.081B |
| September 24, 2026 | 7.109B |
| September 23, 2026 | 7.118B |
| September 22, 2026 | 7.636B |
| September 21, 2026 | 7.586B |
| Date | Value |
|---|---|
| September 18, 2026 | 7.588B |
| September 17, 2026 | 7.910B |
| September 16, 2026 | 7.868B |
| September 15, 2026 | 7.978B |
| September 14, 2026 | 8.470B |
| September 11, 2026 | 8.583B |
| September 10, 2026 | 8.694B |
| September 09, 2026 | 8.882B |
| September 08, 2026 | 9.083B |
| September 04, 2026 | 9.064B |
| September 03, 2026 | 9.157B |
| September 02, 2026 | 9.223B |
| September 01, 2026 | 9.109B |
| August 31, 2026 | 9.022B |
| August 28, 2026 | 8.867B |
| August 27, 2026 | 9.512B |
| August 26, 2026 | 9.777B |
| August 25, 2026 | 9.516B |
| August 24, 2026 | 9.517B |
| August 21, 2026 | 9.738B |
| August 20, 2026 | 9.420B |
| August 19, 2026 | 10.02B |
| August 18, 2026 | 9.567B |
| August 17, 2026 | 9.750B |
| August 14, 2026 | 9.483B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioMarin Pharmaceutical, Inc. | 14.17B |
| Insmed, Inc. | 19.97B |
| Vertex Pharmaceuticals, Inc. | 126.85B |
| Ironwood Pharmaceuticals, Inc. | 889.47M |
| Xencor, Inc. | 1.585B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -83.72M |
| Total Expenses (Quarterly) | 83.72M |
| EPS Diluted (Quarterly) | -2.874 |
| Earnings Yield | -5.12% |
| Normalized Earnings Yield | -5.116 |